Copyright
©The Author(s) 2023.
World J Gastroenterol. Aug 7, 2023; 29(29): 4542-4556
Published online Aug 7, 2023. doi: 10.3748/wjg.v29.i29.4542
Published online Aug 7, 2023. doi: 10.3748/wjg.v29.i29.4542
Primer | Forward sequence (5’-3’) | Reverse sequence (5’-3’) |
KRAS | TGTGGACGAATATGATCCAACA | GCAAATACACAAAGAAAGCCCT |
ERK1 | ATGTCATCGGCATCCGAGAC | GGATCTGGTAGAGGAAGTAGCA |
ERK2 | TACACCAACCTCTCGTACATCG | ATGTCTGAAGCGCAGTAAGATT |
GAPDH | CACCCACTCCTCCACCTTTGA | TCTCTCTTCCTCTTGTGCTCTCTTGC |
miR-204-3p | CAAGTCGCTGGGAAGGCAA | CAGTGCAGGGTCCGAGGT |
U6 | CTCGCTTCGGCAGCACA | AACGCTTCACGAATTTGCGT |
- Citation: Li X, Tibenda JJ, Nan Y, Huang SC, Ning N, Chen GQ, Du YH, Yang YT, Meng FD, Yuan L. MiR-204-3p overexpression inhibits gastric carcinoma cell proliferation by inhibiting the MAPK pathway and RIP1/MLK1 necroptosis pathway to promote apoptosis. World J Gastroenterol 2023; 29(29): 4542-4556
- URL: https://www.wjgnet.com/1007-9327/full/v29/i29/4542.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i29.4542